MediWound (MDWD) Change in Receivables (2013 - 2026)
MediWound (MDWD) posted Change in Receivables of -$478000.0 for Q2 2026, down 221.01% on a QoQ basis from $395000.0 in Q1 2026, and up 71.39% year-over-year from -$278889.0 in Q2 2025.
Powered by 
Analysis
MediWound (MDWD) Change in Receivables (2013 - 2026) Analysis & Trends
MediWound has reported Change in Receivables for 14 years, with the latest figure at -$478000.0 in Q2 2026.
- On a quarterly basis, Change in Receivables rose 71.39% year-over-year to -$478000.0 in Q2 2026; TTM through Jun 2026 was $3.3 million, a 258.46% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, up 381.42% from the prior year.
- Change in Receivables was -$478000.0 for Q2 2026 at MediWound, down from $395000.0 in the prior quarter.
- The five-year high for Change in Receivables was $6.8 million in Q1 2023, with the low at -$5.1 million in Q4 2022.
- Average Change in Receivables over 5 years is $3500.0, with a median of -$444500.0 recorded in 2022.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables slumped 2576.47% in 2022, then jumped 1282.11% in 2025.
- Over 5 years, Change in Receivables stood at -$5.1 million in 2022, then soared by 89.72% to -$528000.0 in 2023, then plunged by 170.08% to -$1.4 million in 2024, then soared by 293.06% to $2.8 million in 2025, then tumbled by 117.36% to -$478000.0 in 2026.
- The last three Change in Receivables figures came in at -$478000.0 (Q2 2026), $395000.0 (Q1 2026), and $2.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1.09 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 333.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 140.20 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 838.50 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -53.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 269.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 | -478,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -478,000.00 |
| Mar 31, 2026 | 395,000.00 |
| Dec 31, 2025 | 2.75 Mn |
| Sep 30, 2025 | 675,000.00 |
| Jun 30, 2025 | -1.67 Mn |
| Mar 31, 2025 | 1.45 Mn |
| Dec 31, 2024 | -1.43 Mn |
| Sep 30, 2024 | -468,000.00 |
| Jun 30, 2024 | 876,000.00 |
| Mar 31, 2024 | -123,000.00 |
| Dec 31, 2023 | -528,000.00 |
| Sep 30, 2023 | 71,000.00 |
| Jun 30, 2023 | -707,000.00 |
| Mar 31, 2023 | 6.82 Mn |
| Dec 31, 2022 | -5.14 Mn |
| Sep 30, 2022 | -421,000.00 |
| Jun 30, 2022 | -1.45 Mn |
| Mar 31, 2022 | -579,000.00 |
| Dec 31, 2021 | 232,000.00 |
| Sep 30, 2021 | 17,000.00 |